Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria.

The in vitro activities of moxalactam (LY127935 [6059S]) and cefotaxime were compared with those of cefoxitin, cefamandole, cefuroxime, carbenicillin, and penicillin by agar dilution susceptibility testing of a variety of anaerobic bacteria. Moxalactam proved to be the most active agent tested again...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Jorgensen, J H, Crawford, S A, Alexander, G A
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1980
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC283895/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6249198/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.17.5.901
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!